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1The occurrence of abdominal aortic aneurysm (AAA) is a significant cause of morbidity and mortality in Western 
countries. According to the UK NHS AAA screening pro-
gram, the prevalence of AAA is 1.2% in all men at age 65 
irrespective of any other risk factor.1 AAA affects a much 
larger proportion of men >65 years of age, particularly in the 
presence of a family history of AAA and a positive history of 
smoking.1,2 In contrast, a history of diabetes mellitus is associ-
ated with a strong protection against the occurrence and pro-
gression of AAA.1–3
AAA is responsible for >11 000 deaths per year in the 
United States and has been consistently found to resist medi-
cal treatment. Aortic wall repair through either endovascu-
lar or open surgical procedures is the only option available, 
with a relatively high risk of early or late morbidity and 
mortality.2,4
The pathophysiology of AAA is complex and associates 
proteolysis of the extracellular matrix (ECM), degeneration 
and loss of vascular smooth muscle cells (VSMCs), alteration 
of endothelial cells, and formation of intraluminal thrombus 
(ILT), along with an infiltration and activation of innate and 
adaptive immune cells.5 The absence of resolution of those 
processes leads to progressive AAA growth and culminates 
in AAA rupture when the aortic wall is unable to sustain the 
hemodynamic overload. Of note, in contrast to thoracic aortic 
aneurysms,6 medial dissection is a rare event in AAA, which 
rather progresses to a complete rupture of the thin aortic wall, 
usually at a stage of advanced aortic dilatation.7
A variety of animal models have been developed to better 
understand the pathophysiology of AAA. Strikingly, however, 
most models fail to reproduce or combine the major features 
of human AAA. Currently, most experimental models of AAA 
© 2017 American Heart Association, Inc.
Arterioscler Thromb Vasc Biol is available at http://atvb.ahajournals.org DOI: 10.1161/ATVBAHA.117.309999
Objective—Current experimental models of abdominal aortic aneurysm (AAA) do not accurately reproduce the major 
features of human AAA. We hypothesized that blockade of TGFβ (transforming growth factor-β) activity—a guardian of 
vascular integrity and immune homeostasis—would impair vascular healing in models of nondissecting AAA and would 
lead to sustained aneurysmal growth until rupture.
Approach and Results—Here, we test this hypothesis in the elastase-induced AAA model in mice. We analyze AAA 
development and progression using ultrasound in vivo, synchrotron-based ultrahigh resolution imaging ex vivo, and a 
combination of biological, histological, and flow cytometry-based cellular and molecular approaches in vitro. Systemic 
blockade of TGFβ using a monoclonal antibody induces a transition from a self-contained aortic dilatation to a model 
of sustained aneurysmal growth, associated with the formation of an intraluminal thrombus. AAA growth is associated 
with wall disruption but no medial dissection and culminates in fatal transmural aortic wall rupture. TGFβ blockade 
enhances leukocyte infiltration both in the aortic wall and the intraluminal thrombus and aggravates extracellular matrix 
degradation. Early blockade of IL-1β or monocyte-dependent responses substantially limits AAA severity. However, 
blockade of IL-1β after disease initiation has no effect on AAA progression to rupture.
Conclusions—Endogenous TGFβ activity is required for the healing of AAA. TGFβ blockade may be harnessed 
to generate new models of AAA with better relevance to the human disease. We expect that the new models will 
improve our understanding of the pathophysiology of AAA and will be useful in the identification of new therapeutic 
targets.  (Arterioscler Thromb Vasc Biol. 2017;37:00-00. DOI: 10.1161/ATVBAHA.117.309999.)
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are performed in rodents, particularly mice, and can be divided 
into 2 main categories.8 The first category includes models that 
induce medial aortic dissection rather than true aortic aneu-
rysmal dilatation, and lead to hemorrhage into a false chan-
nel (intramural hemorrhage), which may ultimately rupture. 
This is the case of the angiotensin II-infusion model, initially 
described by the Daugherty et al9 groups in mice with genetic 
susceptibility to hyperlipidemia and atherosclerosis,10 but also 
models of lysyl oxidase inhibition11–13 and those combining 
mineralocorticoid receptor activation with high salt.14 Despite 
the many advantages of those dissecting AAA models, medial 
dissection is not a major feature of human AAA and is rarely 
an initiating event in the disease process.8 Rather, most human 
AAAs are characterized by aneurysmal dilatation of the aorta 
without false channel formation and culminate in a rupture 
of the thin aortic wall.7 The second category of experimental 
AAAs includes models that induce abdominal aortic dilatation 
without medial dissection, as is the case for the widely used 
elastase-induced or calcium chloride-induced AAA models.8 
However, those models produce moderate aortic dilatation in 
mice and do not induce aortic wall rupture. Finally, although 
leukocyte infiltration, ECM degradation, and medial degen-
eration are observed in almost all the abovementioned models, 
ILT is frequently absent. Thus, there is currently no validated 
AAA model in mice that reproduces and combines the major 
features of human AAA: sustained aneurysmal dilatation of 
the native aorta without false lumen formation, associating 
ECM degradation, medial degeneration, leukocyte infiltration, 
ILT formation, and culminating in transmural rupture of the 
thin aortic wall.
Studies on the mechanisms of aortic aneurysm and dis-
section have shed light on the importance of TGFβ (trans-
forming growth factor-β) activity in the maintenance of aortic 
wall integrity. In mice, genetic disruption of TGFβ signal-
ing in VSMCs early during the disease process promotes the 
development of aneurysms and dissections in the thoracic 
aorta.15,16 Furthermore, blockade of TGFβ activity aggravates 
ECM degradation, medial degeneration, leukocyte infiltration, 
and increases the susceptibility to both thoracic and abdomi-
nal aortic dissection in mice infused with angiotensin II.17,18 
Finally, promotion of TGFβ activity limits the development 
and expansion of experimental AAAs.19 Based on these obser-
vations, we hypothesized that TGFβ may be the critical fac-
tor that maintains aortic wall integrity in mouse models of 
nondissecting AAA (eg, elastase-induced abdominal aortic 
injury) and that blockade of TGFβ activity in those settings 
would aggravate aneurysmal aortic dilatation, induce ILT for-
mation, and promote aortic rupture, thereby reproducing the 
major features of complicated human AAA.
Materials and Methods
Materials and Methods are available in the online-only Data 
Supplement.
Results
Inhibition of TGFβ Activity Induces Abdominal 
Aortic Rupture After Elastase Injury
We combined topical application of elastase on the abdomi-
nal aorta20–22 with systemic blockade of TGFβ activity using 
a neutralizing mouse monoclonal anti-TGFβ.17,18 As already 
described,20–22 periaortic elastase significantly increased aor-
tic diameter (compared with inactive elastase) as assessed 
by serial in vivo ultrasound imaging (Figure 1A and 1B) and 
direct caliper measurement of the external diameter of the 
aorta at the time of euthanization (Figure 1C). Interestingly, 
although aortic dilatation did not progress after day 7 in 
the group receiving active elastase only (Figure 1B), con-
comitant inhibition of TGFβ activity dramatically reduced 
Smad2/3 phosphorylation (Figure I in the online-only Data 
Supplement), steadily enhanced aortic enlargement at the 
site of elastase application throughout the duration of the 
experiment (Figure 1B), and eventually led to sudden death 
because of aortic rupture (Figure 1D and 1E). Staining of 
aortic sections with Orcein revealed significantly enhanced 
elastin degradation in mice cotreated with elastase and anti-
TGFβ (Figure 1F). These results were reproduced in hyper-
lipidemic Apoe−/− mice (Figure IIA in the online-only Data 
Supplement). Systolic blood pressure was not affected by 
the interventions and was similar between all experimental 
groups (Figure IIB in the online-only Data Supplement). Our 
data identify a critical role for TGFβ in preserving aortic wall 
integrity in response to an AAA-inducing insult. The steady 
increase of AAA diameter over the course of the experiment 
and the occurrence of AAA rupture in mice treated with anti-
TGFβ antibody strongly suggest impaired resolution of the 
inflammatory process and altered tissue healing in the absence 
of TGFβ activity (below). This is further supported by our 
finding that TGFβ blockade initiated 14 days after periaortic 
elastase application—a stage of nonprogressing or resolving 
AAA—rapidly induced AAA destabilization and led to fatal 
aortic rupture (Figure III in the online-only Data Supplement).
Synchrotron-Based Ultrahigh Resolution 
Imaging Reveals Features of Human AAA
To characterize this new mouse model of AAA rupture, we 
used synchrotron-based ultrahigh resolution ex vivo imag-
ing on tissue samples from mice that had been euthanized 
at different time points and assessed in details aortic diam-
eter, elastin degradation, adventitial thickness, and the occur-
rence of ILT, medial dissection, or rupture (Figures 2 and 
3). The medial perimeter was highest for locations at which 
elastin degradation was most outspoken (Figure 2A and 
2D; Figure IVA in the online-only Data Supplement). Both 
medial perimeter (Figure 2A through 2C) and elastin degra-
dation (Figure 2C through 2F) were already elevated 3 days 
after elastase application, followed by adventitial thickening 
(Figure 2G through 2I) and the occurrence of ILT (Figure 2J 
through 2L). In nonruptured AAA, elastin degradation did not 
Nonstandard Abbreviations and Acronyms
AAA abdominal aortic aneurysm
ECM extracellular matrix
ILT intraluminal thrombus
SatM segregated nucleus-containing atypical monocyte
TGFβ transforming growth factor-β
VSMC vascular smooth muscle cell
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change after day 3 (Figure 2D and 2E), whereas medial perim-
eter (Figure 2A and 2B), adventitial thickening (Figure 2G and 
2H), and ILT (Figure 2J and 2K) still increased progressively 
at later time points. We observed that animals with ruptured 
AAA had substantially larger medial perimeters (Figure 2C), 
extensive elastin degradation (Figure 2F), and larger ILT 
volumes (Figure 2I) but only moderate although significant 
increase in adventitial thickness (Figure 2L) compared with 
animals with intact AAA. Synchrotron-based ultrahigh resolu-
tion analysis throughout the length of the AAA ruled out the 
occurrence of medial delamination/dissection and attributed 
fatal aortic death to complete transmural rupture of the media 
(Figure 3A). ILT presence was found both in the main aorta 
and the side branches (Figure 3A; Figure IVB and IVC in the 
online-only Data Supplement) and was confirmed on aortic 
sections (Figure 3B). ILT stained positive for platelets (anti-
CD41), leukocytes (Hoechst), and fibrin/fibrinogen as shown 
by confocal microscopy (Figure 3C). Platelets were also found 
in the aortic wall, in between the medial and adventitial layers, 
probably because of hemorrhage (Figure 3D).
Aortic Tissue Remodeling in the 
Elastase/Anti-TGFβ Model
By microscopy on sections from day 14, we confirmed that the 
combination of elastase and anti-TGFβ significantly enhanced 
the accumulation of blood/iron in the aortic wall (Figure 4A) 
and induced profound aortic wall remodeling with smooth 
muscle cell loss in the media (Figure 4B), adventitial neo-
vascularization (Figure 4B), increased accumulation of 
apoptotic cells (Figure 4C), as well as increased MMP activ-
ity (Figure 4D) and reduced collagen content (Figure 4E), 
as compared with the elastase-only group. Proliferation as 
assessed by Ki67 staining was detected in both immune and 
stromal cells of vessels subjected to elastase application but 
was not different between elastase and elastase+anti-TGFβ 
groups (Figure V in the online-only Data Supplement).
Inhibition of TGFβ Activity Increases Immune Cell 
Accumulation in the Aorta After Elastase Injury
Inflammation is another feature of AAA remodeling and 
rupture in humans.5 Using fluorescent microscopy and flow 
Figure 1. Blockade of TGFβ (transforming growth factor-β) activity in mice increases the severity of elastase-induced abdominal aortic 
aneurysm and induces aortic rupture. A and B, Representative ultrasound images at day 14 (D14), and quantification of lumen dilation 
over time in the 3 groups (n=9 per group). Two-way ANOVA and Tukey post hoc analysis. Red stars: ***P<0.001 D7 or D14 vs D0; Black 
stars: ***P<0.001 elastase vs elastase+anti-TGFβ at D14. C, Representative images and quantification of external aortic diameter (mm) by 
caliper at D14 (n=9 per group; Kruskal–Wallis+uncorrected Dunn test). *P<0.05 inactive elastase vs elastase, ***P<0.001 inactive elastase 
vs elastase+anti-TGFβ and elastase vs elastase+anti-TGFβ. D, Survival curve (n=9 per group; log-rank, Mantel–Cox test) and representa-
tive image of aortic rupture in situ (red arrow shows the hematoma) after necropsy (E). **P<0.01 elastase vs elastase+anti-TGFβ. F, Rep-
resentative images of Orcein staining and quantification of elastin degradation at D14 (n=9 per group). Kruskal–Wallis+uncorrected Dunn 
test; *P<0.05 inactive elastase vs elastase and elastase vs elastase+anti-TGFβ, ***P<0.001 inactive elastase vs elastase+anti-TGFβ.
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Figure 2. Synchrotron-based analysis of elastase-induced injury in the presence of anti-TGFβ (transforming growth factor-β). Digital 
analysis of medial aortic perimeter (A–C), elastin degradation (D–F), adventitial thickening (G–I), and intraluminal thrombosis (ILT; J–L) 
after synchrotron imaging. A, D, G, and J, Left dotted line represents the location of the left renal artery; right (colored) dotted lines rep-
resent the iliac bifurcation. Note that the distance between the left renal artery and the iliac bifurcation increased with the progression of 
abdominal aortic aneurysm. C, F, I, and L, No aortic rupture: live mice between day 7 (D7) and D14 (n=12); aortic rupture: death occurred 
between D6 and D14 (n=11). Mann–Whitney U test. *P<0.05, ***P<0.001 no aortic rupture vs aortic rupture.
 by guest on O
ctober 23, 2017
http://atvb.ahajournals.org/
D
ow
nloaded from
 
Lareyre et al  A Human-Like Mouse Model of AAA  5
cytometry analysis, we characterized the inflammatory infil-
trate present in aortic samples at day 14. TGFβ inhibition 
after periaortic elastase application dramatically increased 
the accumulation of T cells, macrophages, and neutrophils, 
as compared with aortic samples treated with elastase only 
(Figure 5). Flow cytometry analysis suggested that macro-
phages were mostly derived from monocytes, given their high 
expression of Ly6B (Figure 5D) and that the T-cell popula-
tion was composed of both CD4+ and CD8+ cells with an acti-
vated phenotype (CD69+; Figure 5D). We also noticed that, 
as described in human AAA, the ILT of mice treated with 
elastase+anti-TGFβ was rich in neutrophils (Figure 5C).
TGFβ Blockade Limits the Accumulation of 
Profibrotic Segregated Atypical Monocytes
Akira et al recently identified a segregated nucleus-containing 
atypical monocyte (SatM) subset derived from a committed 
progenitor downstream of Ly6B/C−FcεRI+ granulocyte/mac-
rophage progenitors. SatM are CEACAM1+MSR1+Ly6B/
C−F4/80−MAC1+ monocytes that differentiate under the 
control of C/EBPβ, home to injured tissues during the heal-
ing phase, and play a crucial role in tissue fibrosis.23 SatM 
do not produce TGFβ; however, C/EBPβ deficiency, which 
eliminates SatM, is associated with substantial reduction of 
TGFβ production.23 Therefore, we tested the impact of TGFβ 
blockade on the accumulation of SatM after elastase injury. 
Interestingly, we found a substantial reduction of SatM in 
the bone marrow, blood, and aortic wall of mice treated with 
neutralizing anti-TGFβ antibody and periaortic elastase, com-
pared with periaortic elastase only (Figure VI in the online-
only Data Supplement). Our results support an important role 
for TGFβ in SatM homeostasis, with potentially important 
consequences on the healing response.
Monocytes/Macrophages Are Necessary 
for the Induction of AAA Rupture After 
Elastase and Anti-TGFβ Treatment
Given the imbalance between inflammatory monocytes and 
SatM in mice treated with anti-TGFβ, we hypothesized that 
monocyte/macrophage depletion using clodronate liposomes 
would limit disease severity and reduce the occurrence of 
aortic rupture. Treatment with clodronate liposomes effec-
tively depleted systemic monocytes (Figure 6A) and aortic 
macrophages (Figure 6B) in comparison with PBS-loaded 
liposomes. Monocyte/macrophage depletion did not abrogate 
aneurysm development (Figure 6C) but led to a marked reduc-
tion of AAA severity (Figure 6C) and completely protected 
against AAA rupture (Figure 6D). This was associated with 
Figure 3. Blockade of TGFβ (transforming growth factor-β) activity after elastase injury induces elastic degradation, adventitial remodel-
ing, aortic rupture, and intraluminal thrombus (ILT) formation. A, Representative 3-dimensional segmentation and raw synchrotron pictures 
of a normal aorta (top row), an aneurysmal aorta (middle row), and a ruptured aneurysm (bottom row). Elastic laminae, adventitial remod-
eling, and ILT formation are color-coded. B, Representative images of ILT analysis in the 3 groups and quantification of the presence of 
ILT. χ2 test; *P<0.05 elastase vs elastase+anti-TGFβ. C, Characterization of ILT by immunofluorescent staining showing the accumulation 
of platelets (CD41-green), fibrin/fibrinogen (red), and cells (Hoechst+) in the lumen side of the aortic wall. D, Representative picture show-
ing the accumulation of platelets in the aortic wall and the formation of neovessels (CD31+) on serial sections.
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a significant reduction of elastin degradation (Figure 6E) and 
increased collagen content (Figure 6F).
Role of IL-1β in the Initiation 
Versus Progression of AAA
To gain more insight into the inflammatory response, we ana-
lyzed mRNA expression of cytokines (by quantitative poly-
merase chain reaction) in the aortic tissue and found that both 
proinflammatory (tumor necrosis factor, interleukin [IL]-6, 
IL-1β, and CXCL1) and anti-inflammatory (TGFβ and IL-10) 
cytokines were induced after elastase injury (Figure VII in 
the online-only Data Supplement). Tumor necrosis factor, 
IL-1β, and CXCL1 reached high levels at day 7, but their 
expression was attenuated at day 14. IL-6 expression showed 
a late increase between day 7 and day 14. IL-10 and TGFβ 
increased at day 7, with variable expression of IL-10 at day 
14. TGFβ blockade on top of elastase application led to sus-
tained elevations and higher levels of IL-1β, CXCL1, and IL-6 
at day 14 after aortic injury but did not alter tumor necrosis 
factor and IL-10 expression. We also detected a slightly higher 
aortic TGFβ expression in the elastase+anti-TGFβ at day 14, 
compared with the elastase-only group.
The kinetics of IL-1β expression in the aortic wall sug-
gested a differential effect in the initiation versus progres-
sion of AAA. To directly assess the implication of IL-1β in 
aortic dilatation and rupture, we compared IL-1β knockout 
Figure 4. Blockade of TGFβ (transforming growth factor-β) activity after elastase injury reproduces histological features of human 
abdominal aortic aneurysm. Aortic cryosections from mice at day 14 (n=9 per group) after surgery were stained for iron accumulation (A, 
Perl staining), the presence of smooth muscle cell (SMC) to assess neovascularization and medial SMCs (αSMA staining, B), apoptosis 
(TUNEL staining, C), gelatinase activity (DG-gelatin, D), and collagen (Sirius red staining, E). Each staining was quantified in the 3 groups 
of mice (n=9 per group). Kruskal–Wallis+uncorrected Dunn test. In A, ***P<0.001 inactive elastase vs elastase+anti-TGFβ, **P<0.01 
elastase vs elastase+anti-TGFβ. In B, ***P<0.001 inactive elastase vs elastase+anti-TGFβ, *P<0.05 elastase vs elastase+anti-TGFβ and 
inactive elastase vs elastase. In C, ***P<0.001 inactive elastase vs elastase+anti-TGFβ, **P<0.01 elastase vs elastase+anti-TGFβ. In D, 
*P<0.05 inactive elastase vs elastase+anti-TGFβ. In E, *P<0.05 elastase vs elastase+anti-TGFβ.
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Figure 5. Blockade of TGFβ (transforming growth factor-β) activity sustains elastase-induced inflammation in the aorta. Aortic cryo-
sections from mice at day 14 (n=9 per group) after surgery were stained for T cells (A), macrophages (B), and neutrophils (C). A–C, 
Quantifications are shown at day 14 (n=9 per group). Kruskal–Wallis+uncorrected Dunn test. In C, the dotted line circles the intralumi-
nal thrombus. D and E, Flow analysis of aortic CD45+ cells at day 14 (n=4 per group). Representative flow chart showing neutrophils, 
macrophages, and T-cell analysis in the aorta of mice treated with elastase or elastase+anti-TGFβ (D), and distribution of immune cells 
in the aorta of each group (E). In A, ***P<0.001 inactive elastase vs elastase+anti-TGFβ, *P<0.05 elastase vs elastase+anti-TGFβ. In B, 
***P<0.001 inactive elastase vs elastase+anti-TGFβ, *P<0.05 elastase vs elastase+anti-TGFβ and inactive elastase vs elastase. In C, 
***P<0.001 inactive elastase vs elastase+anti-TGFβ, **P<0.01 elastase vs elastase+anti-TGFβ.
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(KO) and wild-type mice. We confirmed the absence of 
IL-1β in the plasma of IL-1β KO mice and found that 
CXCL1 and IL-10 were also significantly reduced, sug-
gesting a role for IL-1β in the production of these cyto-
kines (Figure VIIIA in the online-only Data Supplement). 
At day 5 after injury, IL-1β KO mice showed a reduction 
of circulating neutrophils (Figure VIIIB in the online-only 
Data Supplement), in accordance with the reduction of 
plasma CXCL1 levels. As compared with wild-type mice, 
IL-1β KO mice showed a marked protection against aor-
tic dilatation (Figure 7A) and were totally protected against 
AAA rupture induced by elastase and anti-TGFβ treatment 
(Figure 7B). Moreover, the injury induced by elastase and 
TGFβ blockade was dramatically reduced in IL-1β KO 
mice (Figure VIIIC through VIIIF in the online-only Data 
Supplement). To address the role of IL-1β in the progres-
sion and complications of established AAA, we used a 
mouse monoclonal antimouse IL-1β antibody. The antibody 
significantly blocked the induction of CXCL1 by VSMCs 
in response to recombinant IL-1β in vitro (Figure IXA in 
the online-only Data Supplement) and significantly reduced 
plasma levels of CXCL1 and IL-6 in vivo while impair-
ing IL-1β clearance (Figure IXB in the online-only Data 
Supplement). Importantly, however, neutralization of IL-1β 
with this monoclonal anti–IL-1β antibody starting at day 7 
after elastase+anti-TGFβ did not the limit the progression 
Figure 6. Depletion of monocytes/macrophages using clodronate liposomes in mice treated with elastase+anti-TGFβ (transforming 
growth factor-β) prevents aortic rupture. A, Representative flow data of macrophages in the spleen 5 d after liposome injection (n=5 per 
group). B, Representative immunofluorescent staining of macrophages in the aorta on day 14 after surgery (n=7–9 per group). C, Rep-
resentative macroscopic picture and quantification of aortic perimeter of aorta at day 14 after surgery (n=7–9 per group). Mann–Whitney 
U test. *P<0.05 liposome-PBS vs liposome-clodronate. D, Survival curves of mice injected with liposomes (n=7–9 mice per group). Log-
rank, Mantel–Cox test. **P<0.01 liposome-PBS vs liposome-clodronate. E and F, Analysis of elastin and collagen degradation using 
Orcein staining (E) and Sirius red (F), respectively. Mann–Whitney U test (n=7–9 mice per group). In E and F, *P<0.05 liposome-PBS vs 
liposome-clodronate.
Figure 7. Blocking IL-1β does not prevent aortic rupture of established abdominal aortic aneurysm. A, Representative macroscopic pic-
ture and quantification of aortic perimeter of aorta at day 14 after surgery (n=10–12 per group). Mann–Whitney U test. B, Survival curves 
of mice (n=10–12 per group). Log-rank, Mantel–Cox test. C, Wild-type (WT) mice were injected (or not) on day 7 with a neutralizing mouse 
antimouse IL-1β antibody. Injections were repeated on days 9 and 11. Survival curves of mice (n=12 per group). Log-rank, Mantel–Cox 
test. In A and B, ***P<0.001 WT vs IL-1β knockout (KO).
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of established AAA toward fatal rupture (Figure 7C). Taken 
together, our data indicate that IL-1β is important for the 
initiation of AAA but is dispensable for the progression and 
complications of established AAA.
Discussion
Major features of human AAA include ECM degradation, 
medial smooth muscle cell loss and degeneration, infiltration 
and activation of immune cells, ILT formation, progressive aor-
tic dilatation in the absence of medial dissection, and finally 
aortic wall rupture. It is noteworthy that despite the variety of 
experimental models of AAA, none has been reported to com-
bine the major features of human AAA. Most models either 
induce early medial dissection, not transmural aortic wall rup-
ture, or lead to self-contained aortic dilatation. Furthermore, 
most models do not induce ILT formation. A rare occurrence 
of aortic rupture has been reported in elastase-induced AAA in 
rats, not mice, but those rare ruptures occur early after elastase 
application and are because of an overactive exogenous elastase 
rather than a progressive aneurysmal aortic disease that culmi-
nates in aortic wall rupture. Recently, Lu et al22 reported the 
development of a chronic model of AAA in mice after a com-
bination of periaortic elastase application and continuous oral 
administration of the lysyl oxidase inhibitor BAPN. AAA devel-
opment in that model was associated with thrombus formation 
and spontaneous rupture. Despite those interesting human-like 
aneurysm features, the authors provided no evidence for the 
absence of medial dissection, and there was no evidence that 
the few late ruptures had arisen from the aortic wall itself; in 
fact, some deaths were attributed to rupture or dissection of 
small arteries.22 Moreover, BAPN is known to induce medial 
dissections, not transmural ruptures, which lead to intramural, 
not intraluminal, hemorrhage and thrombus formation.11–13
In contrast to previous models, the AAA model we 
describe here in detail associates all the major features of 
human AAA and is potentially of great interest to our under-
standing of the pathophysiology of AAA development, pro-
gression, and complications.
It is remarkable to observe that the transition from a model 
inducing a self-contained aortic dilatation to a human-like 
model of sustained aneurysmal growth culminating in rupture 
is because of the blockade of a single cytokine, TGFβ. This sup-
ports a critical role of TGFβ signaling in the maintenance of 
aortic wall integrity and the protection against AAA progression 
and complications. Mutations in the TGFβ signaling pathway 
are responsible for severe forms of thoracic aortic aneurysms 
and dissections in humans,24 and some studies reported associa-
tions between single-nucleotide polymorphisms in the TGFβ 
signaling components and AAA.25 Moreover, human AAA 
biopsies frequently show loss of 1 copy of TGFβ receptor type 
2 exon 8 in association with a substantial reduction of gene 
expression, suggesting an acquired impairment in the TGFβ 
pathway and local downregulation of TGFβ signaling.26 The 
major sources of TGFβ during AAA development remain to be 
identified. Immune cells, VSMCs, (myo)fibroblasts, and plate-
lets may all contribute to TGFβ production.
How does TGFβ activity control AAA dilatation and pro-
pensity to rupture? TGFβ is well known to control major bio-
logical processes involved in AAA, including ECM remodeling, 
VSMC survival and proliferation, and the activation of the 
immuno-inflammatory response.25 We show here that at least 
some of the protective effect occurs through the control of 
the innate immune response and more particularly, the bal-
ance between inflammatory monocytes/macrophages and 
profibrotic SatM. The specific role of the latter monocyte sub-
set will require further investigation. Moreover, other innate 
immune cells like neutrophils, or adaptive immune cells like T 
cells, may cooperate with monocytes/macrophages and prob-
ably contribute to the process. Note that our study does not 
exclude a role for TGFβ activity in vascular cells and (myo)
fibroblasts. However, deletion of TGFβ receptor signaling 
in VSMC did not lead to aggravation of AAA after elastase 
application in mice.27 The latter result is surprising given the 
major role of VSMC-restricted TGFβ signaling in the protec-
tion against thoracic aortic aneurysms.15,16,28
Our study identifies IL-1β as an important cytokine 
involved in the prevention of AAA development, which is 
an agreement with previous studies performed in less-severe 
models of the disease.29 Surprisingly, however, IL-1β block-
ade did not affect the progression of established AAA toward 
rupture, suggesting a limited role (if any) of IL-1β in advanced 
stages of the disease. The role of IL-1 pathway in human 
AAA is not well understood. Genetic upregulation of IL-1 
receptor antagonist in humans is associated with increased, 
not reduced, susceptibility to AAA.30 Moreover, a recent 
placebo-controlled randomized trial failed to show any ben-
efit of canakinumab (a neutralizing monoclonal anti–IL-1β 
antibody) on AAA progression in patients with small AAAs 
(between 40 and 50 mm; clinicaltrials.gov, NCT02007252). 
The trial included a limited number of patients in each group 
(31 Canakinumab and 33 placebo), and only 2 of 3 patients 
completed the 12-month treatment period. These unexpected 
human data are in disagreement with previous mouse data that 
suggested a detrimental role for IL-1 signaling in the progres-
sion of AAA, using the elastase model.29 However, they seem 
to be in agreement with our findings of a limited role of IL-1β 
in established AAA, using the present elastase+anti-TGFβ 
model, further highlighting the clinical translational relevance 
of this new mouse model.
Another important point to consider is the chronicity and 
sustainability of AAA development and growth over time. 
Most available experimental models of nondissecting AAA 
induce a development of AAA for 7 days and are rapidly self-
contained with no or little AAA progression thereafter; in 
fact, they tend to heal with time in the absence of sustained 
injury. The elastase+BAPN model described recently allows 
the development of a chronic aortic aneurysm and is worth of 
further consideration.22 However, there is no solid evidence 
yet that it is not driven by early medial dissection or that sud-
den death is because of true aortic wall rupture. In this con-
text, our identification of TGFβ as a critical mediator of AAA 
healing is likely to open new avenues for the development 
of chronic models of nondissecting AAA characterized by 
an impaired healing process and sustained growth, until aor-
tic rupture. Our current elastase/anti-TGFβ model produces 
a human-like AAA and a high percentage of AAA rupture 
within 14 days. We think that this model can be adapted to 
produce a nonresolving inflammation that will sustain AAA 
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growth for a longer period, for example, through controlled 
blockade of TGFβ over time (varying the frequency and dose 
of anti-TGFβ), better mimicking the progression of human 
AAA. It is expected that in such a chronic smoldering model, 
the pathogenic mechanisms of AAA growth may differ from 
our current understanding of disease pathogenesis.
Finally, the new model described here may be useful to 
address the role of specific features of AAA, for example, ILT 
formation in AAA progression and susceptibility to rupture. 
Moreover, it will be interesting to examine whether block-
ade of TGFβ activity may be useful in promoting features 
of human-like AAA in other experimental models, like the 
CaCl2 model.
In conclusion, we have shown that current experimental 
mouse models of AAA can be improved to better reproduce 
major features of human AAA and may be harnessed to predict 
response to therapy in the human disease setting. We expect 
that optimized models will provide a better understanding of 
the pathophysiology of AAA and will be useful to identify and 
test new and relevant therapeutic targets.
Acknowledgments
We gratefully acknowledge the assistance of the Department of 
Clinical Biochemistry, University of Cambridge, for the analysis 
of serum biochemical parameters and the Department of Medicine 
Phenotyping hub, University of Cambridge, for assistance with flow 
cytometry. We thank Dr Yoichiro Iwakura (Center for Experimental 
Medicine, Institute of Medical Science, University of Tokyo, Tokyo, 
Japan) for providing the IL-1β–deficient mice.
Sources of Funding
This work was supported by the British Heart Foundation and the 
European Research Council (to Dr Mallat).
Disclosures
None.
References
 1. Jacomelli J, Summers L, Stevenson A, Lees T, Earnshaw JJ. Impact of 
the first 5 years of a national abdominal aortic aneurysm screening pro-
gramme. Br J Surg. 2016;103:1125–1131. doi: 10.1002/bjs.10173.
 2. Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M, van 
Herwaarden JA, Holt PJ, van Keulen JW, Rantner B, Schlösser FJ, Setacci 
F, Ricco JB; European Society for Vascular Surgery. Management of 
abdominal aortic aneurysms clinical practice guidelines of the European 
society for vascular surgery. Eur J Vasc Endovasc Surg. 2011;41(suppl 
1):S1–S58. doi: 10.1016/j.ejvs.2010.09.011.
 3. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT; 
UK Small Aneurysm Trial Participants. Abdominal aortic aneurysm 
expansion: risk factors and time intervals for surveillance. Circulation. 
2004;110:16–21. doi: 10.1161/01.CIR.0000133279.07468.9F.
 4. Patel R, Sweeting MJ, Powell JT, Greenhalgh RM; EVAR Trial 
Investigators. Endovascular versus open repair of abdominal aortic aneu-
rysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 
1 (EVAR trial 1): a randomised controlled trial. Lancet. 2016;388:2366–
2374. doi: 10.1016/S0140-6736(16)31135-7.
 5. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM. Pathophysiology 
and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol. 
2011;8:92–102. doi: 10.1038/nrcardio.2010.180.
 6. Nienaber CA, Clough RE. Management of acute aortic dissection. Lancet. 
2015;385:800–811. doi: 10.1016/S0140-6736(14)61005-9.
 7. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 
2005;365:1577–1589. doi: 10.1016/S0140-6736(05)66459-8.
 8. Sénémaud J, Caligiuri G, Etienne H, Delbosc S, Michel JB, Coscas 
R. Translational relevance and recent advances of animal models of 
abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2017;37:401–
410. doi: 10.1161/ATVBAHA.116.308534.
 9. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes athero-
sclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin 
Invest. 2000;105:1605–1612. doi: 10.1172/JCI7818.
 10. Trachet B, Fraga-Silva RA, Piersigilli A, Tedgui A, Sordet-Dessimoz J, 
Astolfo A, Van der Donckt C, Modregger P, Stampanoni MF, Segers P, 
Stergiopulos N. Dissecting abdominal aortic aneurysm in ang II-infused 
mice: suprarenal branch ruptures and apparent luminal dilatation. 
Cardiovasc Res. 2015;105:213–222. doi: 10.1093/cvr/cvu257.
 11. Kurihara T, Shimizu-Hirota R, Shimoda M, Adachi T, Shimizu H, Weiss 
SJ, Itoh H, Hori S, Aikawa N, Okada Y. Neutrophil-derived matrix metallo-
proteinase 9 triggers acute aortic dissection. Circulation. 2012;126:3070–
3080. doi: 10.1161/CIRCULATIONAHA.112.097097.
 12. Jia LX, Zhang WM, Zhang HJ, Li TT, Wang YL, Qin YW, Gu H, Du J. 
Mechanical stretch-induced endoplasmic reticulum stress, apoptosis and 
inflammation contribute to thoracic aortic aneurysm and dissection. J 
Pathol. 2015;236:373–383. doi: 10.1002/path.4534.
 13. Ren W, Liu Y, Wang X, Jia L, Piao C, Lan F, Du J. β-Aminopropionitrile 
monofumarate induces thoracic aortic dissection in C57BL/6 mice. Sci 
Rep. 2016;6:28149. doi: 10.1038/srep28149.
 14. Liu S, Xie Z, Daugherty A, Cassis LA, Pearson KJ, Gong MC, Guo Z. 
Mineralocorticoid receptor agonists induce mouse aortic aneurysm forma-
tion and rupture in the presence of high salt. Arterioscler Thromb Vasc 
Biol. 2013;33:1568–1579. doi: 10.1161/ATVBAHA.112.300820.
 15. Li W, Li Q, Jiao Y, Qin L, Ali R, Zhou J, Ferruzzi J, Kim RW, Geirsson 
A, Dietz HC, Offermanns S, Humphrey JD, Tellides G. Tgfbr2 disruption 
in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Invest. 
2014;124:755–767. doi: 10.1172/JCI69942.
 16. Hu JH, Wei H, Jaffe M, Airhart N, Du L, Angelov SN, Yan J, Allen JK, 
Kang I, Wight TN, Fox K, Smith A, Enstrom R, Dichek DA. Postnatal 
deletion of the type ii transforming growth factor-β receptor in smooth 
muscle cells causes severe aortopathy in mice. Arterioscler Thromb Vasc 
Biol. 2015;35:2647–2656. doi: 10.1161/ATVBAHA.115.306573.
 17. Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S, 
Huang J, Offenstadt G, Combadière C, Rénia L, Johnson JL, Tharaux 
PL, Tedgui A, Mallat Z. TGF-beta activity protects against inflammatory 
aortic aneurysm progression and complications in angiotensin II-infused 
mice. J Clin Invest. 2010;120:422–432. doi: 10.1172/JCI38136.
 18. Chen X, Rateri DL, Howatt DA, Balakrishnan A, Moorleghen JJ, Cassis 
LA, Daugherty A. TGF-β neutralization enhances angII-induced aortic 
rupture and aneurysm in both thoracic and abdominal regions. PLoS One. 
2016;11:e0153811. doi: 10.1371/journal.pone.0153811.
 19. Dai J, Losy F, Guinault AM, Pages C, Anegon I, Desgranges P, 
Becquemin JP, Allaire E. Overexpression of transforming growth fac-
tor-beta1 stabilizes already-formed aortic aneurysms: a first approach 
to induction of functional healing by endovascular gene therapy. 
Circulation. 2005;112:1008–1015. doi: 10.1161/CIRCULATIONAHA. 
104.523357.
 20. Bhamidipati CM, Mehta GS, Lu G, Moehle CW, Barbery C, DiMusto PD, 
Laser A, Kron IL, Upchurch GR Jr, Ailawadi G. Development of a novel 
murine model of aortic aneurysms using peri-adventitial elastase. Surgery. 
2012;152:238–246. doi: 10.1016/j.surg.2012.02.010.
 21. Busch A, Holm A, Wagner N, Ergün S, Rosenfeld M, Otto C, Baur J, 
Kellersmann R, Lorenz U. Extra- and intraluminal elastase induce mor-
phologically distinct abdominal aortic aneurysms in mice and thus repre-
sent specific subtypes of human disease. J Vasc Res. 2016;53:49–57. doi: 
10.1159/000447263.
 22. Lu G, Su G, Davis JP, Schaheen B, Downs E, Roy RJ, Ailawadi G, 
Upchurch GR Jr. A novel chronic advanced stage abdominal aortic aneu-
rysm murine model. J Vasc Surg. 2017;66:232–242.e4. doi: 10.1016/j.
jvs.2016.07.105.
 23. Satoh T, Nakagawa K, Sugihara F, Kuwahara R, Ashihara M, Yamane F, 
Minowa Y, Fukushima K, Ebina I, Yoshioka Y, Kumanogoh A, Akira S. 
Identification of an atypical monocyte and committed progenitor involved 
in fibrosis. Nature. 2017;541:96–101. doi: 10.1038/nature20611.
 24. Gillis E, Van Laer L, Loeys BL. Genetics of thoracic aortic aneurysm: 
at the crossroad of transforming growth factor-β signaling and vascu-
lar smooth muscle cell contractility. Circ Res. 2013;113:327–340. doi: 
10.1161/CIRCRESAHA.113.300675.
 25. Wang Y, Krishna S, Walker PJ, Norman P, Golledge J. Transforming 
growth factor-β and abdominal aortic aneurysms. Cardiovasc Pathol. 
2013;22:126–132. doi: 10.1016/j.carpath.2012.07.005.
 26. Biros E, Walker PJ, Nataatmadja M, West M, Golledge J. Downregulation 
of transforming growth factor, beta receptor 2 and Notch signaling pathway 
 by guest on O
ctober 23, 2017
http://atvb.ahajournals.org/
D
ow
nloaded from
 
Lareyre et al  A Human-Like Mouse Model of AAA  11
in human abdominal aortic aneurysm. Atherosclerosis. 2012;221:383–
386. doi: 10.1016/j.atherosclerosis.2012.01.004.
 27. Gao F, Chambon P, Offermanns S, Tellides G, Kong W, Zhang X, Li W. 
Disruption of TGF-β signaling in smooth muscle cell prevents elastase-
induced abdominal aortic aneurysm. Biochem Biophys Res Commun. 
2014;454:137–143. doi: 10.1016/j.bbrc.2014.10.053.
 28. Wei H, Hu JH, Angelov SN, Fox K, Yan J, Enstrom R, Smith A, Dichek 
DA. Aortopathy in a mouse model of Marfan syndrome is not mediated 
by altered transforming growth factor beta signaling. J Am Heart Assoc. 
2017;6.
 29. Johnston WF, Salmon M, Su G, Lu G, Stone ML, Zhao Y, Owens GK, 
Upchurch GR Jr, Ailawadi G. Genetic and pharmacologic disruption of 
interleukin-1β signaling inhibits experimental aortic aneurysm forma-
tion. Arterioscler Thromb Vasc Biol. 2013;33:294–304. doi: 10.1161/
ATVBAHA.112.300432.
 30. Chambers JC, Loh M, Lehne B, et al. Epigenome-wide association 
of DNA methylation markers in peripheral blood from Indian Asians 
and Europeans with incident type 2 diabetes: a nested case-control 
study. Lancet Diabetes Endocrinol. 2015;3:526–534. doi: 10.1016/
S2213-8587(15)00127-8.
Highlights
• Endogenous TGFβ (transforming growth factor-β) activity is required for the healing of abdominal aortic aneurysm (AAA).
• Systemic blockade of TGFβ in the elastase-AAA model in mice induces a transition from a self-contained aortic dilatation to a model of sus-
tained aneurysmal growth, associated with the formation of an intraluminal thrombus, and culminates in fatal transmural aortic wall rupture.
• Early blockade of IL1β limits AAA severity. However, blockade of IL1β after disease initiation has no effect on AAA progression to rupture.
• TGFβ blockade may be harnessed to generate new models of AAA with better relevance to the human disease.
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Supplemental Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure I 
Representative photomicrographs and quantification of immunofluorescent staining 
for pSMAD2/3T8, and pSMAD2Ser465/Ser467/pSMAD3Ser423/Ser425 on aortic tissue sections 
from mice treated with inactivated elastase, elastase, or elastase + anti-TGFβ, for 14 
days (n=5-7 mice/group). *P<0.05 compared to elastase group. 
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Supplemental Figure II 
A- Survival curves of WT vs Apoe-/- mice treated with elastase + anti-TGFβ (n=7 
mice/group). 
B- Blood pressure analysis by tail cuff in mice treated with inactivated elastase, 
elastase, or elastase + anti-TGFβ (n=9/group). 
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Supplementary Figure III 
Fourteen days after topical application of elastase on the aorta, one group of mice 
was injected with anti-TGFβ. A- Survival curves: Elastase vs elastase + anti-TGFβ at 
day 14 (n=9-10 mice/group). Two pooled experiments. Log-Rank Mantel Cox test. 
*P<0.05. B- Representative pictures of abdominal aorta at day 28, and aneurysm 
stages (2 pooled experiments). Mann-Whitney test **P<0.01. C- Analysis of elastin 
degradation on cryosections using Orcein staining (n=5-6 mice/group); one 
experiment. Mann-Whitney test **P<0.01. D- Analysis of collagen density on 
cryosections using Sirius Red staining (n=5-6 mice/group); one experiment. Mann-
Whitney test **P<0.01.  
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Supplemental Figure IV  
A- Analysis of the aortic perimeter at the site of elastase application against elastin 
degradation (grade 0: intact elastin, grade 1: 1-20% of elastin is degraded, grade 2: 
21-40% of elastin is degraded, grade 3: 41-60% of elastin is degraded, grade 4: 61-
80% of elastin is degraded, grade 5: 81-100% of elastin is degraded). Several 
images/mouse were analyzed at random sites. B- Intra-luminal thrombus (ILT) 
formation in side branches over time. C- Side branche ILT in non-ruptured versus 
ruptured mice (day 6-14; n=12 mice/group).  
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Supplemental Figure V 
A, B- Analysis by flow cytometry of Ki67 expression in CD45+ and CD45- cells of the 
aorta at day 12 after application of elastase, with or without anti-TGFβ treatment. 
C – Representative pictures of immunostainings for Ki67 (green) and αSMA (Red) on 
aortic tissue sections at day 14. 
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Supplemental Figure VI 
Analysis by flow cytometry of Sat-Mono in bone marrow (A), blood (B), spleen (C) 
and aorta (D) at day 4 and 11 after application of elastase, with or without anti-TGFβ 
treatment. Sat-Mono were gated as CD45+, Ly6B-, F4/80-, CD11b+, Ceacam1+ and 
analyzed for their expression of FcεRI (n=4 mice/group). Mann-Whitney test to 
compare conditions at each time point. In A and B, *p<0.05 Elastase vs Elastase + 
anti-TGFβ at day 7 and day 11. In D, *p<0.05 Elastase vs Elastase + anti-TGFβ at 
day 11. Results were obtained from one experiment. 
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Supplemental Figure VII 
Analysis by Q-PCR of cytokines expression in the aorta of mice treated with 
inactivated elastase, elastase, or elastase + anti-TGFβ. Mann-Whitney at each time 
point, n=3-15 mice/time point. *P<0.05. **P<0.01. Results were obtained from 3 
independent experiments. 
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Supplemental Figure VIII 
A, B- Multiplex analysis of plasma cytokines (A) and circulating neutrophils in the 
blood (B) of WT and IL-1β KO mice 5 days after surgery (n=7 mice per group). C, D- 
Immunofluorescense analysis of T cells (C) and phagocytes (D) at day 14 (n=10-12 
mice/group). E- Analysis of neovascularization and SMC content in the media by 
immunofluorescent staining at day 14 (n=10-12 mice/group). F- Analysis of collagen 
deposition in the aorta by Sirius red staining under polarized light at day 14 (n=10-12 
mice/group). Mann-whithey to compare conditions at each time point. In A and B, 
**p<0.01 WT vs KO, *p<0.05 WT vs KO. In C-F, **p<0.01 WT vs KO, ***p<0.001 WT 
vs KO. Results from A, B and C-F are from 2 independent experiments.  
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Supplemental Figure IX 
A- IL-1β induced CXCL1 secretion by SMCs in vitro after overnight stimulation with 
IL-1β (5 ng/ml), with or without increasing concentration of the neutralizing anti-IL-1β 
antibody. Kruskal-Wallis followed by uncorrected Dunn’s test. * p<0.05 IL-1b vs IL-1β 
+ 10 µg/ml anti-IL-1β. B- Plasma concentration of IL-1β, TNF, IL-6 and CXCL1 in 
mice treated with Elastase + anti-TGFβ with or without anti-IL-1β starting at day 7, for 
7 more days. Data were obtained from 2 independent experiments (n=8-10 
mice/group). Mann-Whitney to compare conditions.***p<0.001,  **p<0.01, *p<0.05 
Vehicle vs anti-IL-1β. 
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Material and Methods 
Mice and procedures 
C57Bl/6J male mice (6-8 week old) from Charles River UK, Apoe-/- mice were 
originally from Charles River, UK. IL-1β deficient were kindly provided by 
Yoichiro Iwakura, Japan 1. Animal experiments were approved by the Home 
Office, UK, and were performed under PPL PA4BDF775. 
The topical application of elastase on the abdominal aorta was done as 
previously described 2-4. The solution of pancreatic porcine elastase (Sigma, 
Type I, ≥4.0 units/mg protein) was filtered through a 0.22 µm filter before the 
experiment. Mice were injected 3 time/week with 250 µg of the mouse anti-
mouse TGFβ (BioXcell, clone 1D11.16.8) i.p. starting on the day of the 
surgery, or 14 days after surgery. 
For monocyte/macrophage depletion, 150 µl of liposome solution (PBS or 
clodronate) were injected i.v. in the tail vein the day before the surgery. 
Injections were repeated i.p. on day 5 and day 10. 
To block IL-1β mice were injected with 150 µg of mouse anti-mouse IL-1β 
(Invivogen, clone 7E3) on day 7, 9, and 11. 
Blood was taken using EDTA (50 µl of 0.5 mM for 500 µl of blood) filled 
syringe by intracardiac puncture. 
Harvested tissues were incubated in 4 % PFA overnight and then kept in 
PBS, at 4°C, for further analysis. Macroscopic aneurysm severity was 
adapted from previous reports 5,6. 
 
Blood pressure 
Non-invasive blood pressure monitoring using tail cuff was done using 
Visitech BP-2000. Mice were trained for blood pressure 2 days prior to taking 
readings. Blood pressures were measured before surgery and later at day 4, 
7, and 14 during the study. 
 
AAA assessment using ultrasound imaging in vivo 
We used Vevo 2100 ultrasound imager (VisualSonics) equipped with MS550D 
22–55 MHz transducer. During imaging, each mouse was anesthetized with 
2% isoflurane administered through an adapted nose cone. The mouse was 
then placed in a supine position on a heated platform to maintain its body 
temperature at approximately 37°C. The hair over the areas being imaged 
was removed with a depilatory cream. Degassed ultrasound gel was used as 
a coupling medium. The ultrasound device was placed on the abdomen of the 
mouse. Sagittal images at the level of the maximal dilatation of the 
aneurysmal portion of the abdominal aorta were acquired in B-mode to 
assess maximum cross-sectional diameter. 
 
Synchrotron-based ultra-high resolution imaging 
The samples were measured at the TOMCAT beamline of the Swiss Light 
Source at the Paul Scherrer Institut (Villigen, Switzerland). The scans were 
performed exploiting the phase-contrast enhancement that was produced 
after positioning our detector at a certain distance from the measured sample, 
also known as propagation based phase contrast 7. This image modality 
applied at TOMCAT provides an edge enhancement that is crucial to 
distinguish features with low density contrast. In order to produce the 
aforementioned phase contrast, the detector was positioned 250 mm from the 
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sample.  TOMCAT was operated at an X-ray photon energy of 21.8 keV with 
an effective pixel size of 1.625. The number of projections acquired for the 
performed tomographic scans was 1501 and the exposure time for each of 
them was 80 milliseconds. Thus, the total sample exposure time was 
approximately of two minutes covering a field of view of 3.5×4 mm2. All 
samples were scanned with a 180 degrees scan except for one sample that 
was too large to fit in the field-of-view, and was therefore scanned with a 360 
degree scan (which approximately doubles the field-of-view). The phase 
retrieval was performed following the algorithm described previously 8 which 
inverts the transport-of-intensity equations fixing the ratio δ/β=217, where δ 
and β are real number which describe the index of refraction of the imaged 
material n, given by n=1-δ+j β.  
 
Flow cytometry 
Aortic sample preparation. Mice were extensively perfused with ice cold PBS 
in the heart right ventricle to drain all the blood out of the system. Aortic 
samples were harvested and kept in PBS, on ice. Abdominal aortic portion 
was cleaned out of all the surrounding tissue, chopped in small pieces and 
incubated in the enzyme solution (Elastase, 1 mg/ml, Worthington; 
Collagenase D, 0.2 mg/ml, Roche; Dispase I, 0.2 U/ml, Stemcell; DNAse I, 0.2 
mg/ml, Roche; in RPMI 1640) for 45 min on a rotating heat block (37°C, 600 
rpm). Enzymatic activity was stopped by adding excessive volume of ice cold 
PBS. Cell suspension and remaining tissue pieces were meshed on a 70 µm 
filter. After extensive wash with PBS, cells were stained with fluorescent 
antibodies. 
For cell analysis, blood and spleen cell suspensions obtained after red blood 
cell lysis (NH4Cl, 150 mMol; KHCO3, 10 mMol; Na2EDTA, 0.1 mMol; in 
distilled water, pH 7.4), as well as aortic and bone-marrow cell suspensions, 
were incubated with Fc block solution (ebiosciences, clone 93, dilution 1/200 
in flow buffer [PBS, 2.5 % BSA, 2 mM EDTA, 0.01 % NaN3]) for 10 minutes at 
4°C. Cells were then stained with fluorescently labelled anti-mouse 
antibodies, diluted in flow buffer at 1/200 (Table I in the online-only Data 
Supplement) for 30 minutes at 4°C, prior to extensive wash and flow 
cytometry analysis. Ki67 staining was done using the ebiosciences 
fix/permeabilisation kit after the surface staining for CD45. 
The cytometric acquisition was performed on a LSR II Fortessa (BD 
biosciences) equipped with 4 lasers (405, 488, 561 and 640 nm). Cell analysis 
was done using BD FACSDiva Software 6.0 and figure-displayed dot plots 
and histograms were obtained using FlowJo software (TreeStar). 
 
Histology and immunofluorescence 
After fixation, tissue samples were incubated overnight in 30% sucrose 
solution before being embedded in OCT and kept at -80°C. Cryosections of 
10 µm were then dried and stained with Orcein (Sigma), Sirius red (Sigma) or 
Perl’s staining kit (Sigma). Elastin degradation stages on aortic sections were 
evaluated as follow: 0, no elastin destruction; 1, 1/4 of the medial 
circumference digested; 2, 1/2 of the medial circumference digested; 3, 3/4 of 
the medial circumference digested; 4, no elastin layer left. Perl’s staining 
stages were defined as: 0, no Perl’s staining; 1, sparse/diffuse blue staining; 
2, few spots of intense blue staining; 3, >5 spots of intense blue staining. 
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For immunofluorescence, cryosections were dried for 30 minutes, before 
being rehydrated in PBS for 10 minutes before the staining. Sections were 
then permeabilized in 0.1 % Triton X-100, 0.1 % Citrate buffer pH 6.0 (Dako) 
for 30 minutes. They were then washed in PBS, and incubated with the 
blocking solution (flow buffer + 5% serum of secondary antibody species, i.e. 
goat or donkey) for 30 minutes, before being incubated with primary 
antibodies diluted in the blocking solution at indicated concentrations (Table II 
in the online-only Data Supplement) overnight at 4°C. Samples were 
extensively washed with PBS and incubated with secondary antibodies diluted 
in the blocking solution at indicated concentrations (Table II in the online-
only Data Supplement) for 4 hours. Samples were again washed extensively 
in PBS, nuclei were counterstained with Hoechst 33342 (Invitrogen) and 
samples were mounted with CC mountTM (Sigma). 
Gelatinase activity was assessed using DQ™ Gelatin from pig skin, 
fluorescein conjugate (Molecular Probes™) according to manufacturer 
instructions. 
Apoptosis assay was performed using In Situ Cell Death Detection Kit 
(Roche). 
Epifluorescence analysis, brightfield and polarized light imaging were done 
using Leica DM6000B microscope and analyzed with accompanying software. 
Images analysis was performed using ImageJ (NIH). 
 
Quantitative real time polymerase chain reaction 
The abdominal aorta was cleared of all the surrounding tissues and snap 
frozen in liquid nitrogen. Tissue samples were pulverised using beads/shaker 
and RNA was prepared using an RNeasy mini kit (Qiagen). Isolated RNA (≥ 
500 ng) was reverse-transcribed using QuantiTect Rev. Transcription Kit 
(Qiagen). Real-time PCR was performed on 2 µl cDNA product (diluted 10 to 
20 times) using Syber Green qPCR mix (Applied Biosystems) on a 7900HT 
Fast Real-Time PCR System (Applied Biosystems) and the primers described 
in Table III in the online-only Data Supplement (Sigma). 
 
Plasma cytokines 
Analysis of plasma cytokines was done using Meso Scale Discovery reagents 
by the Core Biochemical Assay Laboratory, University of Cambridge, 
Cambridge, UK. 
 
Statistical analysis 
Values are expressed as means ± s.e.m. Differences between values were 
analyzed using nonparametric Mann-Whitney (2 groups), Kruskal-Wallis 
followed by Dunn’s test (3 groups), Chi2 (distribution between 2 groups), Log 
Rank, Mantel Cox (2 groups, survival) or 2-way ANOVA followed by Tukey 
post-hoc (3 groups over time), and were considered significant at P<0.05. 
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